India's Sun Pharma says U.S. FDA clears Halol plant

MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.